Targeting the SH2 domain of Stat3 with phosphopeptide mimetic prodrugs leads to tumor growth inhibition and down-regulation of phosphoTyr705 Stat3 and angiogenic pathways

被引：0
|
作者：
McMurray, J. [1 ]
Klostergaard, J. [1 ]
Auzenne, E. J. [1 ]
Liao, W. S. L. [1 ]
Lu, Z. [1 ]
Mandal, P. K. [1 ]
Ramesh, R. [1 ]
Shanker, M. [1 ]
Scott, A. W. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(10)72129-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：134 / 134
页数：1
相关论文
共 50 条
  • [31] Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain
    Page, Brent D. G.
    Fletcher, Steven
    Yue, Peibin
    Li, Zhihua
    Zhang, Xiaolei
    Sharmeen, Sumaiya
    Datti, Alessandro
    Wrana, Jeffrey L.
    Trudel, Suzanne
    Schimmer, Aaron D.
    Turkson, James
    Gunning, Patrick T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (18) : 5605 - 5609
  • [32] Computational screening and molecular dynamics of natural compounds targeting the SH2 domain of STAT3: a multitarget approach using network pharmacology
    Kumar, Sachindra
    Kumar, B. Harish
    Nayak, Raksha
    Pandey, Samyak
    Kumar, Nitesh
    Pai, K. Sreedhara Ranganath
    MOLECULAR DIVERSITY, 2025,
  • [33] Isoform selective inhibition of STAT1 or STAT3 homo-dimerization via peptidomimetic probes: Structural recognition of STAT SH2 domains
    Gunning, Patrick T.
    Katt, William P.
    Glenn, Matthew
    Siddique, Khandaker
    Kim, Joon S.
    Jove, Richard
    Sebti, Said M.
    Turkson, James
    Hamilton, Andrew D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (07) : 1875 - 1878
  • [34] Erratum: Small-molecule inhibitors targeting the DNA-binding domain of STAT3 suppress tumor growth, metastasis and STAT3 target gene expression in vivo
    W Huang
    Z Dong
    Y Chen
    F Wang
    C J Wang
    H Peng
    Y He
    G Hangoc
    K Pollok
    G Sandusky
    X-Y Fu
    H E Broxmeyer
    Z-Y Zhang
    J-Y Liu
    J-T Zhang
    Oncogene, 2016, 35 : 802 - 802
  • [35] Gene therapy in a mouse tumor model of breast cancer by siRNA-mediated down-regulation of STAT3
    Zhou, Yue
    Guo, Baofeng
    Jiang, Pengli
    Jia, Huijie
    Gao, Wen
    Zhou, Qingwei
    Zhang, Ling
    GENE THERAPY AND MOLECULAR BIOLOGY, 2012, 14A : 9 - 16
  • [36] Targeting Protein-Protein Interactions: Suppression of Stat3 Dimerization with Rationally Designed Small-Molecule, Nonpeptidic SH2 Domain Binders
    Gunning, Patrick T.
    Glenn, Matthew P.
    Siddiquee, Khandaker A. Z.
    Katt, William P.
    Masson, Eric
    Sebti, Said M.
    Turkson, James
    Hamilton, Andrew D.
    CHEMBIOCHEM, 2008, 9 (17) : 2800 - 2803
  • [37] Novel STAT3 inhibitors identified by Structure-Based Virtual Ligand Screening incorporating SH2 domain flexibility
    Kong, Ren
    Bharadwaj, Uddalak
    Eckols, Thomas Kris
    Kasembeli, Moses
    Kolosov, Mikhail
    Anh Tran
    Ifelayo, Oluwatomilona I.
    Zhao, Hong
    Wong, Stephen T.
    Tweardy, David J.
    CANCER RESEARCH, 2019, 79 (13)
  • [38] COMP 59-Virtual screening discovered catechol-containing compounds as STAT3 SH2 domain inhibitors
    Hu, Yongbo
    Hao, Wenshan
    Huang, Xinyi
    Chang, Chao-Pei Betty
    Gibbons, Jay
    Xu, Jun
    Humblet, Christine
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 235
  • [39] Down-regulation of STAT3 expression by vector-based small interfering RNA inhibits pancreatic cancer growth
    Huang, Chen
    Yang, Guang
    Jiang, Tao
    Cao, Jun
    Huang, Ke-Jian
    Qiu, Zheng-Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (25) : 2992 - 3001
  • [40] Down-regulation of STAT3 expression by vector-based small interfering RNA inhibits pancreatic cancer growth
    Chen Huang
    World Journal of Gastroenterology, 2011, 17 (25) : 2992 - 3001
12345